FDA Inspection 1204044 — PharmaEssentia Corporation, Taichung Plant
The FDA completed an inspection of PharmaEssentia Corporation, Taichung Plant on April 18, 2023 in Taichung. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 18, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taichung (Taiwan)